TBA


The GlaxoSmithKline pharmaceutical plan where Benlysta is being developed.

The symptoms of Systemic Lupus Erythematosus.

Benlysta could hit the markets late this year or in early 2011.


Newsletter Sign-Up
For all the latest news in the industry, sign up here

Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Industry News
Gallery
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development